Ubs Asset Management Americas Inc Bio Rad Laboratories, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $446 Billion
  • Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 397,171 shares of BIO stock, worth $124 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
397,171
Previous 16,749 2271.31%
Holding current value
$124 Million
Previous $4.04 Million 2655.8%
% of portfolio
0.02%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$241.95 - $303.82 $92 Million - $116 Million
380,422 Added 2271.31%
397,171 $111 Million
Q2 2025

Aug 14, 2025
SELL
$216.56 - $256.68 $79.3 Million - $94 Million
-366,058 Reduced 95.62%
16,749 $4.04 Million
Q1 2025

May 19, 2025
SELL
$243.0 - $367.0 $1.41 Million - $2.14 Million
-5,820 Reduced 1.5%
382,807 $93.2 Million
Q4 2024

Feb 14, 2025
SELL
$313.15 - $374.28 $16.4 Million - $19.6 Million
-52,471 Reduced 11.9%
388,627 $128 Million
Q3 2024

Nov 14, 2024
BUY
$263.97 - $344.64 $1.12 Million - $1.47 Million
4,260 Added 0.98%
441,098 $148 Million
Q2 2024

Aug 13, 2024
BUY
$268.26 - $339.48 $3.94 Million - $4.98 Million
14,681 Added 3.48%
436,838 $119 Million
Q1 2024

May 15, 2024
SELL
$304.11 - $351.99 $24.6 Million - $28.5 Million
-81,051 Reduced 16.11%
422,157 $146 Million
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $19.2 Million - $26 Million
-71,322 Reduced 12.41%
503,208 $162 Million
Q3 2023

Nov 13, 2023
BUY
$350.25 - $422.63 $14.1 Million - $17 Million
40,239 Added 7.53%
574,530 $206 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $48.1 Million - $57.8 Million
114,866 Added 27.39%
534,291 $256 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $8.93 Million - $11.6 Million
25,392 Added 6.44%
419,425 $176 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $7.94 Million - $10.8 Million
19,245 Added 5.13%
394,033 $164 Million
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $13.2 Million - $17 Million
28,416 Added 8.2%
374,788 $186 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $1.31 Million - $1.83 Million
2,495 Added 0.73%
346,372 $195 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $9.73 Million - $10.9 Million
-13,723 Reduced 3.84%
343,877 $260 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $8.27 Million - $10.4 Million
-12,576 Reduced 3.4%
357,600 $267 Million
Q2 2021

Aug 16, 2021
SELL
$576.64 - $649.04 $7.28 Million - $8.19 Million
-12,624 Reduced 3.3%
370,176 $239 Million
Q1 2021

May 14, 2021
SELL
$547.01 - $662.35 $66.1 Million - $80 Million
-120,757 Reduced 23.98%
382,800 $219 Million
Q4 2020

Mar 01, 2021
BUY
$510.68 - $643.45 $60 Million - $75.5 Million
117,413 Added 30.41%
503,557 $294 Million
Q3 2020

Nov 13, 2020
SELL
$454.43 - $535.6 $12 Million - $14.2 Million
-26,428 Reduced 6.41%
386,144 $199 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $15.5 Million - $22.8 Million
46,288 Added 12.64%
412,572 $186 Million
Q1 2020

May 15, 2020
SELL
$320.01 - $409.07 $24 Million - $30.7 Million
-75,058 Reduced 17.01%
366,284 $128 Million
Q4 2019

Feb 14, 2020
BUY
$319.73 - $374.2 $7.3 Million - $8.55 Million
22,837 Added 5.46%
441,342 $163 Million
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $6.48 Million - $7.35 Million
21,281 Added 5.36%
418,505 $139 Million
Q2 2019

Aug 15, 2019
BUY
$286.93 - $312.59 $3.02 Million - $3.29 Million
10,536 Added 2.72%
397,224 $0
Q1 2019

May 14, 2019
SELL
$224.3 - $317.41 $6.31 Million - $8.93 Million
-28,125 Reduced 6.78%
386,688 $0
Q4 2018

Feb 13, 2019
BUY
$220.1 - $309.0 $35.2 Million - $49.5 Million
160,075 Added 62.84%
414,813 $96.3 Million
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $5.62 Million - $6.34 Million
-19,441 Reduced 7.09%
254,738 $0
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $1.54 Million - $1.91 Million
-6,296 Reduced 2.24%
274,179 $0
Q1 2018

May 14, 2018
SELL
$233.97 - $274.11 $18.5 Million - $21.6 Million
-78,936 Reduced 21.96%
280,475 $0
Q4 2017

Feb 09, 2018
SELL
$216.94 - $271.3 $11.3 Million - $14.1 Million
-51,887 Reduced 12.62%
359,411 $0
Q3 2017

Nov 13, 2017
BUY
$212.27 - $242.28 $87.3 Million - $99.6 Million
411,298
411,298 $0

Others Institutions Holding BIO

# of Institutions
437
Shares Held
19.4M
Call Options Held
6K
Put Options Held
3.3K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email